Nasopharyngeal Diseases  >>  Teysuno (gimeracil/oteracil/tegafur)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
NCT01403259: SOX as Salvage Treatment in Nasopharyngeal Carcinoma

Terminated
2
16
RoW
S-1 plus oxaliplatin, S-1, Oxaliplatin
Fudan University
Nasopharyngeal Carcinoma
12/14
12/15

Download Options